Robotic-assisted Training After Upper Arm Fracture (RASTA)

April 22, 2020 updated by: Corinna Nerz, Robert Bosch Gesellschaft für Medizinische Forschung mbH

Robotic-assisted Training After Upper Arm Fracture - a Multicentre, Controlled and Randomized Intervention Study

In this study, patients with upper arm fracture will receive an additive robotic-assisted training using the Armeo®Spring robot for three weeks on the injured arm in addition to conventional physio- and occupational therapy. The supportive treatment and execution of specific exercises on the Armeo®Spring should lead to improved recovery of function and mobility of the upper arm compared to conservatively treated patients.

Study Overview

Status

Completed

Conditions

Detailed Description

60 Patients aged between 35 and 70 years with proximal humeral fracture and surgical treatment will be recruited in three different clinics in Germany and randomised into an intervention and a control group. Participants will be assessed before randomisation and followed up after completing an intervention period of 3 weeks and additionally after 3, 6 and 12 months. Baseline assessment will assess cognition (SOMC), level of pain in the affected arm, ability to work, gait speed (10m walk), disability of the arm, shoulder and hand (DASH), as well as the range of motion of the affected arm (goniometer measurement), visual acuity and motor function of orthopaedic patients (WMFT-O). Clinical follow up directly after intervention will assess disability of the arm, shoulder and hand (DASH), the range of motion and motor function (WMFT-O). Primary outcome parameter will be the DASH and secondary outcome parameter will be the WMFT-O. The long-term results will be assessed prospectively by a postal follow-up. All patients will receive conventional occupational- and physiotherapy. The intervention group will receive an additive robotic-assisted training using the Armeo®Spring robot for three weeks.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ludwigshafen, Germany, 67071
        • Berufsgenossenschaftliche Klinik Ludwigshafen
      • Murnau am Staffelsee, Germany, 82418
        • Berufsgenossenschaftliche Klinik Murnau
      • Stuttgart, Germany, 70376
        • Robert-Bosch-Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • surgical treatment of the shoulder joint after upper arm fracture classified as type AO 11
  • movement-stable fracture
  • Inclusion between the fourth and the seventh week after surgery

Exclusion Criteria:

  • limited cognition as defined by a score in Short-Orientation-Memory-Concentration Test (SOMC) less than 10 points
  • inadequate level of pain during movement of the affected shoulder joint (pain score >5 on a visual analogue pain scale)
  • strongly limited vision or hearing
  • heart failure (New York Heart Association stage III-IV) or COPD (Chronic Obstructive Pulmonary Disease) Gold stage III-IV
  • walking speed <0.8m/sec
  • isolated tuberculum majus fracture of the humerus (AO 11, A1)
  • fractures with involvement of the glenoid cavity
  • double fractures
  • injury of the plexus or the axillaris nerve

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Intervention Armeo®Spring
The intervention group will receive conventional occupational- and physiotherapy and an additive robotic-assisted training using the Armeo®Spring robot for three weeks.
The robotic-assisted training will be performed using the clinically evaluated Armeo®Spring medical device (Hocoma AG, Zurich, Switzerland). By means of a sensory orthosis, arm movements will be supported and transmitted to a computer system and visually shown on a screen.
ACTIVE_COMPARATOR: Control group
The control group will receive conventional occupational- and physiotherapy.
The control group will receive conventional occupational- and physiotherapy over 3 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in disability of the arm, shoulder and hand (DASH)
Time Frame: DASH will be assessed before randomisation and followed up after completing an intervention period of 3 weeks and additionally after 3, 6 and 12 months for assessing the change
subjective questionnaire for assessing the disability of the arm, shoulder and hand
DASH will be assessed before randomisation and followed up after completing an intervention period of 3 weeks and additionally after 3, 6 and 12 months for assessing the change

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the WMFT-O
Time Frame: WMFT will be assessed before randomisation and followed up after completing an intervention period of 3 weeks for assessing the change
WMFT-O is an objective test for assessing the disability of the shoulder
WMFT will be assessed before randomisation and followed up after completing an intervention period of 3 weeks for assessing the change
Change in ROM
Time Frame: ROM will be assessed before randomisation and followed up after completing an intervention period of 3 weeks for assessing the change
a goniometer-based measurement of the active range of motion (ROM) of the shoulder joint
ROM will be assessed before randomisation and followed up after completing an intervention period of 3 weeks for assessing the change
Change in grip strength
Time Frame: grip strength will be assessed before randomisation and followed up after completing an intervention period of 3 weeks for assessing the change
measurement of the grip strength using the Jamar dynamometer
grip strength will be assessed before randomisation and followed up after completing an intervention period of 3 weeks for assessing the change

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 15, 2016

Primary Completion (ACTUAL)

December 15, 2018

Study Completion (ACTUAL)

December 1, 2019

Study Registration Dates

First Submitted

March 22, 2017

First Submitted That Met QC Criteria

March 28, 2017

First Posted (ACTUAL)

April 4, 2017

Study Record Updates

Last Update Posted (ACTUAL)

April 24, 2020

Last Update Submitted That Met QC Criteria

April 22, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Shoulder Injury

Clinical Trials on Intervention Armeo®Spring

3
Subscribe